Clinical Trial: A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo

U.S., June 16 -- ClinicalTrials.gov registry received information related to the study (NCT07647237) titled 'A Clinical Trial of Multiple Doses of GR2301 Injection Combined With Phototherapy in Trial Participants With Vitiligo' on May 25.

Brief Summary: This is a randomized, double-blind, placebo-controlled Phase Ib/II clinical trial of multiple subcutaneous injections of GR2301 in combination with phototherapy to evaluate the tolerability, safety, pharmacokinetics, and preliminary efficacy in trial participants with vitiligo. The trial will be conducted in two stages: a dose-escalation stage (Phase Ib) and an expansion cohort stage (Phase II).

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Vitiligo

Intervention: ...